
This review article describes the identification of the zzso zzso zzso as the hallmark of chronic zzso zzso zzso as well as the development of a specific inhibitor of this zzso zzso the zzso zzso zzso zzso The authors discuss the results of a phase I and three phase II trials reporting the efficacy of zzso as treatment for zzso patients and propose two simplified zzso that may help to guide decision-making for the individual zzso 

